Johnson & Johnson (JNJ) stock dipped early Tuesday after the S&P 500 pharma giant reported adjusted income of $2.80 per share on nearly$24 billion in third-quarter sales.On average, analysts polled by FactSet expected J&J to earn $2.76 a share on$23.76 billion in sales. During the year-earlier period, Johnson & Johnson had $2.42 earnings per share and$22.47 billion in sales.The company also announced plans to separate its orthopedics business into a standalone company called DePuy Synthes. Following the ...